世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

黄斑変性症治療薬市場：世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測


Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

黄斑変性症治療の世界市場規模は、2022年に89億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.2%の成長率（CAGR）を示し、2028年までに129億米ドルに達すると予測しています。 黄斑変性... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス 		2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		145 英語

　

サマリー

黄斑変性症治療の世界市場規模は、2022年に89億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.2%の成長率（CAGR）を示し、2028年までに129億米ドルに達すると予測しています。

黄斑変性症は、眼を侵す神経変性眼疾患であり、視野の中心部がぼやけたり、視力が低下したりする。視野の盲点、視覚の歪み、低照度下での見えにくさなどが特徴です。黄斑変性症の治療法としては、血管新生阻害剤、光線力学的レーザー治療、コンタクトレンズ、移行レンズなどが一般的に用いられています。レーザー治療では、専用のコンタクトレンズを目の患部に挿入し、レーザーで血管を塞ぎます。血管の閉塞や漏れを防ぐために、血管新生阻害剤を使用します。黄斑変性症の治療を適時に行うことで、視力を向上させ、慢性的な失明を引き起こすリスクを最小限に抑えることができます。

黄斑変性症治療薬の市場動向：
加齢黄斑変性と肥満の増加が、市場成長を促進する重要な要因の1つです。食生活の変化や座りがちな生活習慣の増加が、黄斑変性症の発症に繋がっています。さらに、スマートフォン、ノートパソコン、テレビの利用が増え、長時間かつ過度なスクリーンタイムが続いていることも、この疾患の発生に影響を与えています。さらに、異常な血管の発達を防ぐためにアデノ随伴ウイルス（AAV）を体内に注入する網膜遺伝子治療法の開発が、市場の成長を後押ししています。これに伴い、医療インフラの大幅な改善も市場成長にプラスの影響を与えています。また、革新的で効果的な医薬品を開発するための広範な研究開発活動や、公衆衛生を促進するためのさまざまな政府の取り組みも、市場の成長を促進すると予想されます。

主要な市場セグメンテーション
IMARC Groupは、黄斑変性症治療の世界市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、市場をタイプ、病期、投与経路、エンドユーザーに基づいて分類しています。

タイプ別構成比：

ドライ型加齢黄斑変性症
湿潤型加齢黄斑変性症

病期別の内訳：

アーリーステージ
中級ステージ
後期

投与経路別構成比：

静脈内投与ルート
硝子体内ルート

エンドユーザー別構成比：

ホスピタルズ
外来手術センター
その他

地域別構成比：

北アメリカ
ユーエスエー
カナダ
アジア太平洋
中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中近東・アフリカ

競争環境：
業界の競争環境は、Aerie Pharmaceuticals Inc.、Bausch Health Companies Inc.、Bayer AG、F. Hoffmann-La Roche Ltd.、Iveric Bio Inc.、Novartis AG、Panoptica、Pfizer Inc、Fio Pharmaceuticals、Regenon Pharmaceuticals Inc、Regenxbio Inc、および Santen Pharmaceutical Co. "の主要企業のプロファイルと共に検討されています。Ltd.となりました。

本レポートで回答した主な質問

1.2022年の黄斑変性症治療薬の世界市場規模は？
2.2023-2028年の黄斑変性症治療薬世界市場の予想成長率は？
3.黄斑変性症治療薬の世界市場を牽引する主要因は何か？
4.COVID-19が黄斑変性症治療薬の世界市場に与えた影響とは？
5.黄斑変性症治療薬の世界市場のタイプ別内訳はどうなっていますか？
6.黄斑変性症治療薬の世界市場における病期別の内訳はどうなっているのか？
7.黄斑変性症治療薬の世界市場において、投与経路に基づく内訳はどうなっていますか？
8.黄斑変性症治療薬の世界市場のエンドユーザー別の内訳はどうなっていますか？
9.黄斑変性症治療の世界市場における主要地域は？
10.黄斑変性症治療薬の世界市場における主要プレイヤー/企業は？

ページTOPに戻る


目次

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Macular Degeneration Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Dry Age-related Macular Degeneration
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Wet Age-related Macular Degeneration
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Stage of Disease
    7.1    Early Stage 
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intermediate Stage 
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Late Stage 
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Route of Administration
    8.1    Intravenous Route
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Intravitreal Route
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Ambulatory Surgical Center
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Aerie Pharmaceuticals Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bausch Health Companies Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche Ltd
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Iveric Bio Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Novartis AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Panoptica
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Pfizer Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Phio Pharmaceuticals
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
        15.3.10    Regeneron Pharmaceuticals Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Regenxbio Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Santen Pharmaceutical Co. Ltd.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2022
Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2022
Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2022
Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2022
Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2022
Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2023-2028
Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
Table 8: Global: Macular Degeneration Treatment Market: Key Players

　

ページTOPに戻る


　

Summary

The global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

Macular Degeneration Treatment Market Trends:
The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global macular degeneration treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, stage of disease, route of administration and end user.

Breakup by Type:

Dry Age-related Macular Degeneration
Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

Early Stage
Intermediate Stage
Late Stage

Breakup by Route of Administration:

Intravenous Route
Intravitreal Route

Breakup by End User:

Hospitals
Ambulatory Surgical Center
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in This Report

1. What was the size of the global macular degeneration treatment market in 2022?
2. What is the expected growth rate of the global macular degeneration treatment market during 2023-2028?
3. What are the key factors driving the global macular degeneration treatment market?
4. What has been the impact of COVID-19 on the global macular degeneration treatment market?
5. What is the breakup of the global macular degeneration treatment market based on the type?
6. What is the breakup of the global macular degeneration treatment market based on the stage of disease?
7. What is the breakup of the global macular degeneration treatment market based on the route of administration?
8. What is the breakup of the global macular degeneration treatment market based on the end user?
9. What are the key regions in the global macular degeneration treatment market?
10. Who are the key players/companies in the global macular degeneration treatment market?



ページTOPに戻る


Table of Contents

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Macular Degeneration Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Dry Age-related Macular Degeneration
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Wet Age-related Macular Degeneration
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Stage of Disease
    7.1    Early Stage 
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intermediate Stage 
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Late Stage 
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Route of Administration
    8.1    Intravenous Route
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Intravitreal Route
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Ambulatory Surgical Center
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Aerie Pharmaceuticals Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bausch Health Companies Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche Ltd
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Iveric Bio Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Novartis AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Panoptica
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Pfizer Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Phio Pharmaceuticals
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
        15.3.10    Regeneron Pharmaceuticals Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Regenxbio Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Santen Pharmaceutical Co. Ltd.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2022
Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2022
Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2022
Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2022
Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2022
Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2023-2028
Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
Table 8: Global: Macular Degeneration Treatment Market: Key Players

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.